Update in diagnosis, management, and outcomes of acute disseminated encephalomyelitis (ADEM) in the era of myelin oligodendrocyte glycoprotein associated disease (MOGAD): A Scoping Review

2025/03/23 by Bassal, Frederick, Vaishnavi Vaidyanathan, De Los Santos, Tracy
#Diseases #Encaphalitis #Immune System Diseases #Medical Specialties #Medicine and Health Sciences #Nervous System Diseases #Neuro-Immunology #Neurology #Pediatric #Pediatrics #acute disseminated encephalomyelitis

paper · doi:10.17605/osf.io/72c53

Abstract

The objective for our review would be provide valuable clinical information for pediatric neurologists by providing an update in clinical definition, management, and outcomes in patients with seronegative ADEM in the setting of all the newest updates in the field of pediatric neuroimmunology.

Related

• Acute disseminated encephalomyelitis
• Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
• 腐蝕銅版画の防蝕被膜について : アブラアム・ボスの『腐蝕銅版画技法』の場合を中心に
• Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis
• PediDemi -- A Pediatric Demyelinating Lesion Segmentation Dataset